Aurora Cannabis (ACB) Income towards Parent Company (2017 - 2026)
Aurora Cannabis (ACB) posted quarterly Income towards Parent Company of $4.4 million for Q1 2026, up 174.14% year-over-year from $1.6 million in Q1 2025, and down 98.85% quarter-over-quarter from $384.6 million in Q4 2025.
Aurora Cannabis (ACB) Income towards Parent Company (2017 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Income towards Parent Company for 10 consecutive years, with $4.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Income towards Parent Company rose 174.14% year-over-year to $4.4 million; the TTM figure through Mar 2026 stood at -$548.6 million (up 48.66% YoY), while the FY2026 annual figure was -$42.7 million, down 110.48% from the prior year.
- Income towards Parent Company declined to $4.4 million in Q1 2026 per ACB's latest filing, from $384.6 million in the prior quarter.
- Across five years, Income towards Parent Company topped out at $410.6 million in Q2 2024 and bottomed at -$1.3 billion in Q1 2022.
- Historically, Income towards Parent Company has averaged $60.0 million across 5 years, with a median of $359.5 million in 2023.
- Annual changes were most pronounced in 2022 — Income towards Parent Company sank 4195.43% — and 2026, when it soared 174.14%.
- Aurora Cannabis' Income towards Parent Company stood at -$545.4 million in 2022, then soared by 169.56% to $379.4 million in 2023, then rose by 8.11% to $410.1 million in 2024, then declined by 6.22% to $384.6 million in 2025, then sank by 98.85% to $4.4 million in 2026.
- Business Quant data shows ACB's Income towards Parent Company at $4.4 million in Q1 2026, $384.6 million in Q4 2025, and $386.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Aurora Cannabis | 235.30 Mn | 162.99 Mn | 25.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.43 Mn |
| Dec 31, 2025 | 384.62 Mn |
| Sep 30, 2025 | 386.51 Mn |
| Jun 30, 2025 | 398.33 Mn |
| Mar 31, 2025 | -5.97 Mn |
| Dec 31, 2024 | 410.12 Mn |
| Sep 30, 2024 | 398.17 Mn |
| Jun 30, 2024 | 410.62 Mn |
| Mar 31, 2024 | -1.65 Mn |
| Dec 31, 2023 | 379.35 Mn |
| Sep 30, 2023 | 375.79 Mn |
| Jun 30, 2023 | 354.16 Mn |
| Mar 31, 2023 | 359.55 Mn |
| Dec 31, 2022 | -545.38 Mn |
| Sep 30, 2022 | -515.60 Mn |
| Jun 30, 2022 | -488.98 Mn |
| Mar 31, 2022 | -1.28 Bn |
| Dec 31, 2021 | 1.55 Bn |
| Sep 30, 2021 | -12.00 Mn |
| Jun 30, 2021 | -87.26 Mn |